FDA Home Page | Dockets
Home Page | Dockets Contacts
and Location | Operating Status
Dockets Entered
On October 22, 2003 Table of Contents | |||||||||||
Docket # | Title | ||||||||||
1976N-0052N | OTC Nasal Decongestants | ||||||||||
1978N-0036L | OTC Laxative | ||||||||||
1981N-0022 | OTC Weight Control Drug Products for Human Use | ||||||||||
1997S-0162 | 30-Day Structure Function Claim Notification Letters Dietary | ||||||||||
2002P-0120 | Request the immediate ban of Meridia (sibutramine) | ||||||||||
2003D-0290 | Compounding of Drugs for Use in Animals Compliance Policy Guide | ||||||||||
2003D-0412 | International Conference on Harmonisation; Draft Guidance on E2D Postapproval Safety Data Management: Definitions and Standards for Expedited Reporting | ||||||||||
2003N-0472 | Statement of Work for the Evaluation of First Cycle Review Performance; Availability | ||||||||||
1976N-0052N | OTC Nasal Decongestants | ||||||||||
MT 12 | D. DeLap, Ms. Walling/FDA and Dr. Walter Kerman/Yale U | Vol #: | 77 | ||||||||
1978N-0036L | OTC Laxative | ||||||||||
LET 201 | HFD-560 to Purdue Pharma, LP | Vol #: | 121 | ||||||||
1981N-0022 | OTC Weight Control Drug Products for Human Use | ||||||||||
MT 9 | Dr. DeLap, Ms. Walling/FDA and Dr. Walter Kerman/Yale U. | Vol #: | 95 | ||||||||
1997S-0162 | 30-Day Structure Function Claim Notification Letters Dietary | ||||||||||
LET 11295 | Botanical Laboratories, Inc. | Vol #: | 86 | ||||||||
LET 11296 | Botanical Laboratories, Inc. | Vol #: | 86 | ||||||||
LET 11297 | Botanical Laboratories, Inc. | Vol #: | 86 | ||||||||
LET 11298 | Solstice Medicine Company | Vol #: | 86 | ||||||||
LET 11299 | Your Vitamins | Vol #: | 86 | ||||||||
LET 11300 | Your Vitamins | Vol #: | 86 | ||||||||
LET 11301 | Your Vitamins | Vol #: | 86 | ||||||||
LET 11302 | Solgar Vitamin & Herbs | Vol #: | 86 | ||||||||
LET 11303 | Enzymatic Therapy Natural Medicines | Vol #: | 86 | ||||||||
LET 11304 | PhytoPharmica Natural Medicines | Vol #: | 86 | ||||||||
LET 11305 | Enzymatic Therapy Natural Medicines | Vol #: | 86 | ||||||||
LET 11306 | Enzymatic Therapy Natural Medicines | Vol #: | 86 | ||||||||
LET 11307 | Natural 2U, LLC | Vol #: | 86 | ||||||||
LET 11308 | NOW Foods | Vol #: | 86 | ||||||||
LET 11309 | NOW FOODS | Vol #: | 86 | ||||||||
LET 11310 | NOW FOODS | Vol #: | 86 | ||||||||
LET 11311 | Perrigo Company of South Carolina | Vol #: | 86 | ||||||||
LET 11312 | Perrigo Company of South Carolina | Vol #: | 86 |
LET 11313 | Perrigo Company of South Carolina | Vol #: | 86 | ||||||
LET 11314 | Perrigo Company of South Carolina | Vol #: | 86 | ||||||
LET 11315 | Standard Process Inc. | Vol #: | 86 | ||||||
LET 11316 | Standard Process Inc. | Vol #: | 86 | ||||||
LET 11317 | Global Chinese herbs Depot, Inc. | Vol #: | 86 | ||||||
LET 11318 | Enzymatic Therapy Natural Medicines | Vol #: | 86 | ||||||
LET 11319 | Perrigo Company of South Carolina | Vol #: | 86 | ||||||
LET 11320 | Perrigo Company of South Carolina | Vol #: | 86 | ||||||
LET 11321 | Natural Factors Nutritional Products Inc. | Vol #: | 86 | ||||||
LET 11322 | Natural Factors Nutritional Products Inc. | Vol #: | 86 | ||||||
LET 11323 | Phytomer Corp. | Vol #: | 86 | ||||||
LET 11324 | Enzymatic Therapy Natural Medicines | Vol #: | 86 | ||||||
LET 11325 | Millennium Biotechnologies, Inc. | Vol #: | 86 | ||||||
LET 11326 | Millennium Biotechnologies, Inc. | Vol #: | 86 | ||||||
LET 11327 | Bayer Corporation | Vol #: | 87 | ||||||
LET 11328 | NOW FOODS | Vol #: | 87 | ||||||
LET 11329 | A.L.A. Corporation | Vol #: | 87 | ||||||
LET 11330 | A.L.A. Corporation | Vol #: | 87 | ||||||
LET 11331 | Natural Organics Inc. | Vol #: | 87 | ||||||
LET 11332 | Natural Organics Inc. | Vol #: | 87 | ||||||
LET 11333 | Natural Organics Inc. | Vol #: | 87 | ||||||
LET 11334 | Natural Organics Inc. | Vol #: | 87 | ||||||
LET 11335 | Natural Organics Inc. | Vol #: | 87 | ||||||
LET 11336 | Natural Organics Inc. | Vol #: | 87 | ||||||
2002P-0120 | Request the immediate ban of Meridia (sibutramine) | ||||||||
C
4 Tab A | Abbott Laboratories (Abbott) | Vol #: | 1 | ||||||
2003D-0290 | Compounding of Drugs for Use in Animals Compliance Policy Guide | ||||||||
C 1 | Janet M. Grossnickle | Vol #: | 1 | ||||||
2003D-0412 | International Conference on Harmonisation; Draft Guidance on E2D Postapproval Safety Data Management: Definitions and Standards for Expedited Reporting | ||||||||
C 4 | Abbott Laboratories | Vol #: | 1 | ||||||
2003N-0472 | Statement of Work for the Evaluation of First Cycle Review Performance; Availability | ||||||||
BKG 1 | Background Material | Vol #: | 1 | ||||||
NAD 1 | FDA | Vol #: | 1 |
Dockets Home| Dockets
Contacts and Location | Operating Status
| Item
Code Definitions | Federal
Register
FDA Home Page | Search FDA
Site | A-Z Index | Contact
FDA | Privacy | Accessibility